健康中国战略下药食同源产业的政策驱动与路径探索
Policy-driven and Path Exploration for the Food-Drug Homology Industry under the Healthy China Strategy
在“健康中国2030”战略深入推进与“十五五”规划开局之年的背景下,药食同源产业作为中医药与大健康产业融合创新的关键载体,其发展被赋予新的时代内涵。本文系统梳理了产业在“十四五”末期的成就与瓶颈,并紧密结合2026年国家政策新导向与AI智慧技术发展新趋势,对产业升级路径进行前瞻性探讨。产业在规模扩张、业态创新方面成效显著,但标准、创新与产业链协同等深层问题依然存在。国家最新政策在强化标准与监管、鼓励科技创新与融合、推动高水平开放等方面持续加力;“十五五”规划对发展新质生产力、推进数字技术与实体经济深度融合的部署,为产业智能化、绿色化转型指明了方向;以大模型为代表的AI智慧技术正从生产优化、精准服务向研发创新深度渗透。据此,本文提出以“标准-智慧-生态”为核心的升级路径:构建智慧化标准与溯源体系、打造AI驱动的研发创新范式、深化产业链智慧协同与集群化发展、拓展“药食同源+”智慧化融合新场景、实施基于数字平台的国际化与人才战略,以期为产业在新时代实现高质量发展提供系统性解决方案。
Against the backdrop of the deepening implementation of the “Healthy China 2030” strategy and the opening year of the 15th Five- Year Plan, the food-as-medicine industry, as a key carrier for the integration and innovation of traditional Chinese medicine and the health industry, has been endowed with new contemporary significance. This paper systematically reviews the achievements and bottlenecks of the industry at the end of the 14th Five-Year Plan period, closely aligning with the new national policy orientation in 2026 and emerging trends in AI-powered intelligent technologies, to conduct a forward-looking exploration of industrial upgrading pathways. While the industry has achieved remarkable progress in scale expansion and business model innovation, deep-seated issues such as standards, innovation, and industrial chain coordination remain unresolved. The latest national policies continue to intensify efforts in strengthening standards and regulation, encouraging technological innovation and integration, and promoting high-level openness. The 15th Five-Year Plan’s deployment to develop new-quality productivity and deepen the integration of digital technologies with the real economy has charted the course for the industry’s intelligent and green transformation. AI-powered intelligent technologies, represented by large models, are increasingly permeating from production optimization and precision services to R&D innovation. Accordingly, this paper proposes an upgrade path centered on “standards-intelligence-ecosystem”: establishing intelligent standards and traceability systems, creating AI-driven R&D innovation paradigms, enhancing intelligent collaboration and cluster development across the industrial chain, expanding new intelligent integration scenarios of “food-as-medicine+”, and implementing internationalization and talent strategies based on digital platforms, aiming to provide systematic solutions for the industry’s high-quality development in the new era.
| [1] |
中共中央, 国务院 . “健康中国2030”规划纲要[Z]. 北京: 人民出版社, 2016. |
| [2] |
国家发展和改革委员会 . 中华人民共和国国民经济和社会发展第十五个五年规划纲要[Z]. 2026. |
| [3] |
2026年国务院政府工作报告[R]. 2026. |
| [4] |
国家卫生健康委员会, 国家市场监督管理总局 . 关于进一步推动药食同源产业高质量发展的若干意见[Z]. 2025. |
| [5] |
张敏, 刘勇 . 健康中国战略下药食同源产业的政策导向与发展路径[J]. 中国食品学报, 2021, 21(8): 301-308. |
| [6] |
李建科, 赵艳 . 药食同源功能性食品的研发与市场前景[J]. 食品科学, 2020, 41(11): 305-312. |
| [7] |
王丽, 张强 . 我国药食同源产业标准化发展现状与对策[J]. 中国标准化, 2022(12): 189-192. |
| [8] |
中国医药保健品进出口商会 . 2025年中国药食同源产品进出口统计报告[R]. 2026. |
| [9] |
艾瑞咨询 . 2026年中国AI+大健康产业发展白皮书[R]. 2026. |
| [10] |
孙伟, 陈明 . 人工智能在中医药传承与创新中的应用前景与挑战[J]. 中国中药杂志, 2025, 50(1): 1-8. |
/
| 〈 |
|
〉 |